Maximize your in vivo imaging preclinical cancer research with our IVISense™ Oncology Fluorescent Imaging Panel.
The development of novel and safer cancer therapeutics that target specific molecular targets and broader disease-related processes is crucial to combating this disease. in vivo preclinical imaging systems along with fluorescent probes can help researchers understand complex biological processes related to cancer, validate potential molecular targets, and assess therapeutic response in a whole animal model, non-invasively, longitudinally, and in real-time.
IVISense Oncology fluorescent panel contains six carefully selected fluorescent probes that enable researchers to visualize and quantify various tumor-related biological processes to better understand the disease as well as aid in the development of new cancer therapies.
The IVISense Oncology Fluorescent Imaging Panel includes the following five probes:
| Part Number | Fluorescent Probe | Biological Target |
|---|
| NEV10001EX | IVISense Pan Cathepsin 750 FAST (ProSense 750EX) | Pan-cathepsin activatable probe:
Lysosomal marker of a variety of inflammatory cells |
| NEV10040 | IVISense Folate Receptor 680 (FolateRSense 680) | Folate receptor targeted probe:
Marker on inflammatory cells; metabolic marker on tumor cells |
| NEV10054EX | IVISense Vascular 680 (AngioSense 680EX) | Vascular probe:
Leaks into sites of neovascular formation |
| NEV10168 | IVISense MMP 750 FAST (MMPSense 750 FAST) | Pan-MMP activatable probe:
Secreted protease from inflammatory cells and tumor cells |
| NEV10873 | IVISense Integrin Receptor 750 (IntegriSense 750) | αVβ3 integrin targeted probe:
Marker on activated tumors and neovasculature |
For research use only. Not for use in diagnostic procedures.
